Melanie Spears

515 total citations
29 papers, 343 citations indexed

About

Melanie Spears is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Melanie Spears has authored 29 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Cancer Research and 11 papers in Molecular Biology. Recurrent topics in Melanie Spears's work include HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Estrogen and related hormone effects (6 papers). Melanie Spears is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Genomics and Diagnostics (9 papers) and Estrogen and related hormone effects (6 papers). Melanie Spears collaborates with scholars based in United Kingdom, Canada and United States. Melanie Spears's co-authors include John M.S. Bartlett, Karen J. Taylor, David Cameron, Jeremy Thomas, Carrie Cunningham, Elizabeth A. Mallon, Alison F. Munro, Richard Marcellus, Irina Kalatskaya and Cindy Q. Yao and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Melanie Spears

26 papers receiving 337 citations

Peers

Countries citing papers authored by Melanie Spears

Since Specialization

Citations

This map shows the geographic impact of Melanie Spears's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Spears with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Spears more than expected).

Fields of papers citing papers by Melanie Spears

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Spears. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Spears. The network helps show where Melanie Spears may publish in the future.

Co-authorship network of co-authors of Melanie Spears

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Spears. A scholar is included among the top collaborators of Melanie Spears based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Spears. Melanie Spears is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotyping 2025 ·Breast Cancer Research ·Alison Cheung, Dan Wang, (unknown), (unknown), Melanie Spears, John M.S. Bartlett, Lincoln Stein, Jane Bayani, Martin J. Yaffe	1
2	Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)? 2025 ·The Breast ·(unknown), Gregory R. Pond, Jane Bayani, Sarah L. Barker, Melanie Spears, Elizabeth Mallon, Karen J. Taylor, Annette Hasenburg, (unknown), Luc Dirix, Elma Meershoek‐Klein Kranenbarg, Cornelis J.�H. van de Velde, Daniel Rea, Lisa Vandermeer, John Hilton, John M.S. Bartlett, Mark Clemons	0
3	Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial 2024 ·Clinical Cancer Research ·John M.S. Bartlett, Keying Xu, (unknown), Gregory R. Pond, (unknown), Melanie Spears, Ranelle Salunga, Elizabeth Mallon, Karen J. Taylor, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Cornelis J.�H. van de Velde, Daniel Rea, Catherine A. Schnabel, Kai Treuner, Jane Bayani	2
4	Assessment of risk of overall and late distant recurrence by Breast Cancer Index in postmenopausal women with early-stage, HR+ breast cancer in the TEAM trial. 2023 ·Journal of Clinical Oncology ·John M.S. Bartlett, Keying Xu, (unknown), Gregory R. Pond, Yi Zhang, Melanie Spears, Ranelle Salunga, Elizabeth Mallon, Karen J. Taylor, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Cornelis J.�H. van de Velde, Daniel Rea, Catherine A. Schnabel, Kai Treuner, Jane Bayani	1
5	138MO Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial 2022 ·Annals of Oncology ·JMS Bartlett, Keying Xu, Jacqueline Wong, Gregory R. Pond, (unknown), Melanie Spears, Ranelle Salunga, E. Mallon, Karen J. Taylor, Annette Hasenburg, Christos Markopoulos, (unknown), Caroline Seynaeve, (unknown), (unknown), Catherine A. Schnabel, Kai Treuner, Jane Bayani	5
6	Abstract 3131: Tumour spatial heterogeneity in breast cancer and the impact on clinical management 2021 ·Cancer Research ·Jane Bayani, Quang M. Trinh, (unknown), (unknown), (unknown), (unknown), Alison Cheung, James G. Mainprize, Quaid Morris, Melanie Spears, Martin J. Yaffe, Lincoln Stein, John M.S. Bartlett	1
7	Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer 2018 ·Journal of Ovarian Research ·Taryne Chong, (unknown), Cindy Q. Yao, Linda M. Liao, (unknown), Paul C. Boutros, John M.S. Bartlett, Melanie Spears	26
8	ISOWN: accurate somatic mutation identification in the absence of normal tissue controls 2017 ·Genome Medicine ·Irina Kalatskaya, Quang M. Trinh, Melanie Spears, John D. McPherson, John M.S. Bartlett, Lincoln Stein	30
9	Copy-number and targeted sequencing analyses to identify distinct prognostic groups: Implications for patient selection to targeted therapies amongst anti-endocrine therapy resistant early breast cancers. 2017 ·Journal of Clinical Oncology ·Jane Bayani, Elizabeth Kornaga, (unknown), Gun Ho Jang, Irina Kalatskaya, Quang M. Trinh, Cindy Q. Yao, Julie Livingstone, Annette Hasenburg, D. G. Kieback, Christos Markopoulos, Luc Dirix, Paul C. Boutros, Melanie Spears, Lincoln Stein, Daniel Rea, John M.S. Bartlett	1
10	Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer 2016 ·Breast Cancer Research ·Marsela Braunstein, Linda M. Liao, (unknown), (unknown), Karen J. Taylor, Paul M. Krzyzanowski, Irina Kalatskaya, Cindy Q. Yao, Lincoln Stein, Paul C. Boutros, Christopher Twelves, Richard Marcellus, John M.S. Bartlett, Melanie Spears	20
11	A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial 2016 ·Oncotarget ·Melanie Spears, (unknown), Alister D’Costa, Bingshu E. Chen, Cindy Q. Yao, Paul C. Boutros, Margot J. Burnell, Mark N. Levine, Patti O’Brien, Lois E. Shepherd, John M.S. Bartlett	2
12	A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials 2015 ·Oncotarget ·Melanie Spears, Fouad Yousif, (unknown), Paul C. Boutros, Alison F. Munro, Chris Twelves, Kathleen I. Pritchard, Mark N. Levine, Lois E. Shepherd, John M.S. Bartlett	7
13	Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance 2014 ·BMC Cancer ·(unknown), Melanie Spears, (unknown), Karen J. Taylor, Linda M. Liao, Carrie Cunningham, Maryou B. Lambros, Alan Mackay, Cindy Q. Yao, Jorge S. Reis‐Filho, John M.S. Bartlett	17
14	Expression of activated type I receptor tyrosine kinases in early breast cancer 2012 ·Breast Cancer Research and Treatment ·Melanie Spears, (unknown), (unknown), (unknown), (unknown), (unknown), Jeremy Thomas, G.R. Kerr, W Jack, Ian Kunkler, David Cameron, U Chetty, John M.S. Bartlett	3
15	Proximity ligation assays for isoform‐specific Akt activation in breast cancer identify activated Akt1 as a driver of progression 2012 ·The Journal of Pathology ·Melanie Spears, Carrie Cunningham, Karen J. Taylor, Elizabeth A. Mallon, Jeremy Thomas, G.R. Kerr, W Jack, Ian Kunkler, David Cameron, U Chetty, John M.S. Bartlett	26
16	In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer 2011 ·Breast Cancer Research and Treatment ·Melanie Spears, Karen J. Taylor, Alison F. Munro, Carrie Cunningham, Elizabeth A. Mallon, Chris Twelves, David Cameron, Jeremy Thomas, John M.S. Bartlett	59
17	The p160 ER co-regulators predict outcome in ER negative breast cancer 2011 ·Breast Cancer Research and Treatment ·Melanie Spears, Steffi Oesterreich, Ilenia Migliaccio, (unknown), Susan G. Hilsenbeck, (unknown), (unknown), Alison F. Munro, Jeremy Thomas, G.R. Kerr, W Jack, Ian Kunkler, David Cameron, U Chetty, John M.S. Bartlett	14
18	In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues 2010 ·British Journal of Cancer ·Michaela Aubele, Melanie Spears, Natalie Ludyga, Herbert Braselmann, Annette Feuchtinger, Karen J. Taylor, (unknown), Gert Auer, (unknown), Heinz Höfler, Manfred Schmitt, John M.S. Bartlett	27
19	The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer 2009 ·Expert Opinion on Therapeutic Targets ·Melanie Spears, John M.S. Bartlett	21
20	Human Epidermal Growth Factor Receptor Dimerization Analysis in Breast Cancer Diagnosis 2009 ·Molecular Diagnosis & Therapy ·Melanie Spears, John M.S. Bartlett	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact